Heart CT scan for relatives with high or low Lp(a)
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years old or older.
- You must have a blood test result showing either very high Lp(a) (≥150 nmol/L) or very low Lp(a) (<50 nmol/L).
- You were identified through family screening for high Lp(a) at the Amsterdam UMC Vascular Medicine clinic.
- You must not have a history of heart disease, stroke, or blocked arteries.
- You must not have used statins in the past or currently.
- You must have normal kidney function (eGFR ≥30).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether simple electronic letters can motivate people with heart disease to better manage their health, especially their cholesterol levels. If you have high Lp(a) — a type of cholesterol linked to heart risk — you may also get a special letter about that.
This study tests whether a new medicine called lepodisiran can shrink plaque in heart arteries for adults with high Lp(a) (a type of cholesterol linked to heart disease) who have had a heart event or are at serious risk. The trial uses CT scans to monitor changes in your arteries.
This study looks at whether a blood test for lipoprotein(a) can help predict heart disease risk when combined with a CT scan of the heart. If you are at intermediate risk for heart disease and are having a CT scan, this study may help you understand your risk better.
This trial tests ways to help doctors check for high Lp(a), a risk factor for heart disease, in patients who need it. The study looks at whether special strategies increase testing rates in cardiology centers that currently test less than 15% of eligible patients.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.
Hear when a new Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.